| Vertex Signs Multispecific T-Cell Engager Collaboration with AbCellera for Autoimmune Diseases |
Abstract
pdf
html
|
|
Nikita Negi |
|
| Johnson & Johnson Pays Sail Biomedicines US$785M Upfront to Develop In Vivo CAR-T Therapies for Autoimmune Disease |
Abstract
pdf
html
|
|
Sanya Sekhri |
|
| Innovent Signs US$1.1B Licensing Alliance with Spero for IBI355 (SP001), for the Teatment Immune-Mediated Diseases |
Abstract
pdf
html
|
|
Naini Anand |
|
| Novartis Expands Oncology Portfolio with US$1.5 B Acquisition of Myricx |
Abstract
pdf
html
|
|
Sanya Sekhri |
|
| Argenx to Acquire Forte Biosciences for US$2.2 B |
Abstract
pdf
html
|
|
Ayush Saxena |
|
| Supernus and Indivior Merge to Create a CNS-Focused Drug Company |
Abstract
pdf
html
|
|
Ayush Saxena |
|
